vs
Side-by-side financial comparison of NOODLES & Co (NDLS) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $122.1M, roughly 1.3× NOODLES & Co). NOODLES & Co runs the higher net margin — -7.5% vs -82.0%, a 74.5% gap on every dollar of revenue. On growth, NOODLES & Co posted the faster year-over-year revenue change (-4.1% vs -22.7%). NOODLES & Co produced more free cash flow last quarter ($-2.8M vs $-36.6M). Over the past eight quarters, NOODLES & Co's revenue compounded faster (-1.2% CAGR vs -11.5%).
Noodles & Company is an American fast-casual restaurant that offers international and American noodle dishes in addition to soups and salads. Noodles & Company was founded in 1995 by Aaron Kennedy and is headquartered in Broomfield, Colorado. The company went public in 2013 and recorded a $457 million revenue in 2017. In mid-2022, there were 458 Noodles & Company locations across 31 states.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
NDLS vs PTCT — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $122.1M | $164.7M |
| Net Profit | $-9.2M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | -5.2% | -43.3% |
| Net Margin | -7.5% | -82.0% |
| Revenue YoY | -4.1% | -22.7% |
| Net Profit YoY | 32.8% | -104.8% |
| EPS (diluted) | $-0.20 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $164.7M | ||
| Q3 25 | $122.1M | $211.0M | ||
| Q2 25 | $123.8M | $178.9M | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | $122.8M | $213.2M | ||
| Q3 24 | $127.4M | $196.8M | ||
| Q2 24 | $121.4M | $186.7M | ||
| Q1 24 | $124.3M | $210.1M |
| Q4 25 | — | $-135.0M | ||
| Q3 25 | $-9.2M | $15.9M | ||
| Q2 25 | $-9.1M | $-64.8M | ||
| Q1 25 | — | $866.6M | ||
| Q4 24 | $-6.8M | $-65.9M | ||
| Q3 24 | $-13.6M | $-106.7M | ||
| Q2 24 | $-6.1M | $-99.2M | ||
| Q1 24 | $-6.1M | $-91.6M |
| Q4 25 | — | -43.3% | ||
| Q3 25 | -5.2% | 1.4% | ||
| Q2 25 | -5.2% | -19.5% | ||
| Q1 25 | — | 82.5% | ||
| Q4 24 | -3.9% | -76.2% | ||
| Q3 24 | -9.0% | -27.7% | ||
| Q2 24 | -3.4% | -21.5% | ||
| Q1 24 | -3.7% | -21.6% |
| Q4 25 | — | -82.0% | ||
| Q3 25 | -7.5% | 7.5% | ||
| Q2 25 | -7.3% | -36.3% | ||
| Q1 25 | — | 73.7% | ||
| Q4 24 | -5.5% | -30.9% | ||
| Q3 24 | -10.7% | -54.2% | ||
| Q2 24 | -5.1% | -53.1% | ||
| Q1 24 | -4.9% | -43.6% |
| Q4 25 | — | $-1.63 | ||
| Q3 25 | $-0.20 | $0.20 | ||
| Q2 25 | $-0.20 | $-0.83 | ||
| Q1 25 | — | $10.04 | ||
| Q4 24 | $-0.15 | $-0.85 | ||
| Q3 24 | $-0.30 | $-1.39 | ||
| Q2 24 | $-0.14 | $-1.29 | ||
| Q1 24 | $-1.64 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.7M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-38.9M | $-205.3M |
| Total Assets | $280.6M | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.9B | ||
| Q3 25 | $4.7M | $1.7B | ||
| Q2 25 | $1.4M | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | $3.3M | $1.1B | ||
| Q3 24 | $1.8M | $1.0B | ||
| Q2 24 | $1.3M | $1.1B | ||
| Q1 24 | $3.0M | $884.8M |
| Q4 25 | — | $-205.3M | ||
| Q3 25 | $-38.9M | $-155.8M | ||
| Q2 25 | $-13.9M | $-206.5M | ||
| Q1 25 | — | $-185.8M | ||
| Q4 24 | $3.7M | $-1.1B | ||
| Q3 24 | $9.6M | $-1.1B | ||
| Q2 24 | $21.9M | $-980.2M | ||
| Q1 24 | $27.2M | $-893.9M |
| Q4 25 | — | $2.9B | ||
| Q3 25 | $280.6M | $2.6B | ||
| Q2 25 | $319.4M | $2.6B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | $340.5M | $1.7B | ||
| Q3 24 | $346.3M | $1.8B | ||
| Q2 24 | $360.4M | $1.9B | ||
| Q1 24 | $368.1M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.3M | $-34.3M |
| Free Cash FlowOCF − Capex | $-2.8M | $-36.6M |
| FCF MarginFCF / Revenue | -2.3% | -22.3% |
| Capex IntensityCapex / Revenue | 5.8% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-7.5M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-34.3M | ||
| Q3 25 | $4.3M | $-66.3M | ||
| Q2 25 | $4.0M | $-58.3M | ||
| Q1 25 | — | $870.1M | ||
| Q4 24 | $5.8M | $-30.0M | ||
| Q3 24 | $4.7M | $-77.0M | ||
| Q2 24 | $7.0M | $-71.5M | ||
| Q1 24 | $164.0K | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | $-2.8M | $-69.7M | ||
| Q2 25 | $1.1M | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | $-1.3M | $-33.8M | ||
| Q3 24 | $-4.5M | $-77.5M | ||
| Q2 24 | $-1.6M | $-78.8M | ||
| Q1 24 | $-15.2M | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | -2.3% | -33.1% | ||
| Q2 25 | 0.9% | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | -1.1% | -15.8% | ||
| Q3 24 | -3.5% | -39.4% | ||
| Q2 24 | -1.4% | -42.2% | ||
| Q1 24 | -12.2% | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | 5.8% | 1.6% | ||
| Q2 25 | 2.4% | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 5.8% | 1.8% | ||
| Q3 24 | 7.2% | 0.3% | ||
| Q2 24 | 7.1% | 4.0% | ||
| Q1 24 | 12.3% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NDLS
| Food And Beverage | $119.6M | 98% |
| Franchise | $2.5M | 2% |
PTCT
Segment breakdown not available.
